COMORBIDITY IN OSTEOARTHRITIS
Introduction. Comorbid pathology, which accompanies most chronic non-communicable diseases, not only negatively affects the treatment of patients, but also significantly worsens their quality of life. Osteoarthritis (OA) is an age-related disease characterized by high comorbidity.
Aim: to identify the most common comorbid conditions in patients with OA.
Materials and methods: Study Design: The study is prospective, controlled. The study period is from September 01 to December 01, 2022. in the KGP on the REM "City Polyclinic" No. 5. 60 patients with a reliable diagnosis of OA were examined, including 12 men (20%), 48 women (80%), mean age (63.37±10.1 years), mean duration of illness (6.89±7.45). All patients signed an informed consent prior to the start of the study. Statistical processing of the obtained data was carried out using the Statistica-6 program, where p<0.05 was considered significant.
Results. Mostly dominated by women 86.7%, over 50 years old. Out of 60 patients with OA, gonarthrosis was detected in 44 (73.3%), coxarthrosis in 4 (6.7%), generalized form - in 12 (20%), with the prevalence of patients with X-ray stage II. All 60 patients with OA had concomitant diseases, of which 92.2% had two or more comorbid pathologies. The leading place in the structure of comorbidity was occupied by pathology of the cardiovascular system in 31 (51.7%) patients, including arterial hypertension (AH) in 18 (58%) patients, coronary heart disease (CHD) in 13 (42%) patients, with this was dominated by angina pectoris II functional class. The mean systolic pressure at baseline and over time was 123.39±17.02 mm Hg. Art., indicators of diastolic pressure initially and in dynamics were within 82.62±5.05. In second place is endocrine pathology in 16 (26.7%) patients. Six (10%) patients had osteoporosis (OP) and received bisphosphonates.
Conclusions. Almost all OA patients have a comorbid pathology, while in 92.2% of cases patients have two or more concomitant diseases. The most common comorbidities are diseases of the cardiovascular system (51.7%, including hypertension in 58% of patients), diseases of the endocrine system in 16 patients (26.7%), of which obesity in 8 (50%), Type 2 diabetes in 5 (31.3%), hypothyroidism in 3 (18.7%), respectively, and OP in 10% of patients.
Number of Views: 558
Category of articles:
Original article
Bibliography link
Nogaeva M.G., Khabizhanova V.B., Tazhiyeva A.Е., Goremykina M.V., Issayeva S.M., Dilmanova D.S. Comorbidity in osteoarthritis // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (6), pp. 106-115. doi 10.34689/SH.2024.26.6.013Related publications:
EPIDEMIOLOGY, RESOURCE DISTRIBUTION, AND MANAGEMENT CHALLENGES OF CHRONIC HEART FAILURE IN KAZAKHSTAN: A NATIONAL RETROSPECTIVE ANALYSIS
PREVALENCE OF POLYMORPHISMS IN WARFARIN METABOLISM-RELATED GENES AMONG THE KAZAKH POPULATION
NEUROLOGICAL COMPLICATIONS IN EXTRACORPOREAL MEMBRANE OXYGENATION: RISK FACTORS FOR THE DEVELOPMENT OF ACUTE CEREBROVASCULAR EVENTS
THE EFFECT OF REPAGLINIDE AND METFORMIN ON EXTERNAL RESPIRATORY FUNCTION IN PATIENTS WITH DIABETES AND ISCHEMIC HEART DISEASE ASSOCIATED WITH OBESITY
RETROSPECTIVE ANALYSIS OF PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF THE LOWER EXTREMITY ARTERIES IN THE ABAI REGION OF THE REPUBLIC OF KAZAKHSTAN